Early Drug Development Center
At the Early Drug Development Center, we perform early clinical research. At our center, patients with solid tumors and rare types of cancer can be treated with promising experimental new drugs.
Specialized center for phase 1 and 2 clinical cancer research
This department has been established as a separate and specialized unit within the Netherlands Cancer Institute (NKI) – Antoni van Leeuwenhoek (AVL), and is entirely focused on phase 1 and 2 clinical research.
At the Early Drug Development Center (EDDC) we are entirely focused on early clinical research
This means that phase 1 and phase 2 studies are being conducted. We have been established as a separate and more specialized unit within the Netherlands Cancer Institute (NKI). The EDDC is fully equipped for efficient and reliable execution of early clinical research. This unit can serve as a professional partner for multidisciplinary working groups, supported with medical, administrative, and nursing assistance.
"Within the Nederlands Cancer Institute there's an average of about 450 clinical studies."
This page contains the most recent news updates of all that is happening at the EDDC.
At the Early Drug Development Center, we aim to give patients the chance to join clinical trials, helping us to optimize cancer treatment methods.
For all inqueries, please reach out to us by email or phone, or visit us at Plesmanlaan 121 in Amsterdam.